Sarah A. Reilly

Chronic kidney disease (CKD) treatment burden among low-income primary care patients

Linda S. Kahn, Bonnie M. Vest, Nethra K. Madurai et al. · Chronic Illness · 2014 · 45 citations · Full text

Nursing, Nephrology, Chronic Illness Self-management +16

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

J. Andrew Livingston, Jean‐Yves Blay, Jonathan C. Trent et al. · Clinical Cancer Research · 2024 · 34 citations

Medicine, Oncology, Pharmacology +14

Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies

Courtney D. DiNardo, Michael R. Savona, Ashwin Kishtagari et al. · Blood · 2023 · 21 citations

Medicine, Oncology, Pharmacology +12

Perceived cancer risk and risk attributions among African-American residents of a low-income, predominantly African-American neighborhood

Heather Orom, Karen O’Quin, Sarah A. Reilly et al. · Ethnicity and Health · 2014 · 16 citations

Medicine, Oncology, Population Health Sciences +17

A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies

Courtney D. DiNardo, Amir T. Fathi, Ashwin Kishtagari et al. · Clinical Cancer Research · 2025 · 10 citations

Medicine, Hematology, Pharmacology +16